Curaleaf’s lead researchers Dr Mikael Sodergren and Simon Erridge have been nominated for a Contribution to Science award!
Their dedication to advancing research in the cannabis industry is making a real impact in the scientific community. We are beyond proud of their contributions, including:
Together they set up Europe’s largest patient registry for Curaleaf Clinic, allowing for unprecedented insights into patient outcomes and the real-world impact of medical cannabis treatments.
They lead the Medical Cannabis Research Group at Imperial College London, focused on developing a range of novel cannabinoid treatments for various types of pain and cancer.
They’ve authored and published over 50 peer-reviewed papers on medical cannabis, contributing invaluable knowledge to the global scientific community.